from pharmadata import pharmaverseadam
meta = pharmaverseadam.meta('adtte_onco')
print(f"Rows: {meta.number_rows:,} Columns: {meta.number_columns}")Rows: 512 Columns: 20adtte_onco
adtte_onco
Time to Event Analysis for Oncology
Structure: One or more records per subject per analysis parameter per analysis timepoint
Variables
Show variable specs
shape: (20, 5)
| variable | label | type | mandatory | role |
|---|---|---|---|---|
| str | str | str | str | str |
| "STUDYID" | "Study Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "USUBJID" | "Unique Subject Identifier" | "String" | "Yes" | "Identifier Variables for BDS Datasets" |
| "ASEQ" | "Analysis Sequence Number" | "Int32" | "No" | "Identifier Variables for BDS Datasets" |
| "AGE" | "Age" | "Float64" | "No" | "ADSL Subject Demographics Variables" |
| "SEX" | "Sex" | "String" | "No" | "ADSL Subject Demographics Variables" |
| "ARM" | "Description of Planned Arm" | "String" | "No" | "ADSL Treatment Variables" |
| "ARMCD" | "Planned Arm Code" | "String" | "No" | null |
| "ACTARM" | "Description of Actual Arm" | "String" | "No" | "ADSL Treatment Variables" |
| "ACTARMCD" | "Actual Arm Code" | "String" | "No" | null |
| "ADT" | "Analysis Date" | "Date" | "No" | "Timing Variables for BDS Datasets" |
| "PARAM" | "Parameter" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "PARAMCD" | "Parameter Code" | "String" | "Yes" | "Analysis Parameter Variables for BDS Datasets" |
| "AVAL" | "Analysis Value" | "Float64" | "No" | "Analysis Parameter Variables for BDS Datasets" |
| "STARTDT" | "Time-to-Event Origin Date for Subject" | "Date" | "No" | "Time-to-Event Variables for BDS Datasets" |
| "CNSR" | "Censor" | "Int32" | "No" | "Time-to-Event Variables for BDS Datasets" |
| "EVNTDESC" | "Event or Censoring Description" | "String" | "No" | "Time-to-Event Variables for BDS Datasets" |
| "CNSDTDSC" | "Censor Date Description" | "String" | "No" | "Time-to-Event Variables for BDS Datasets" |
| "SRCDOM" | "Source Data" | "String" | "No" | "Datapoint Traceability Variables" |
| "SRCVAR" | "Source Variable" | "String" | "No" | "Datapoint Traceability Variables" |
| "SRCSEQ" | "Source Sequence Number" | "Int32" | "No" | "Datapoint Traceability Variables" |
Examples
from great_docs import tbl_explorer
from pharmadata import pharmaverseadam
tbl_explorer(pharmaverseadam.adtte_onco.head(10))PolarsRows10Columns20 | ||||||||||||||||||||
STUDYID str |
USUBJID str |
ASEQ i32 |
AGE f64 |
SEX str |
ARM str |
ARMCD str |
ACTARM str |
ACTARMCD str |
ADT date |
PARAM str |
PARAMCD str |
AVAL f64 |
STARTDT date |
CNSR i32 |
EVNTDESC str |
CNSDTDSC str |
SRCDOM str |
SRCVAR str |
SRCSEQ i32 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | CDISCPILOT01 | 01-701-1015 | 1 | 63 | F | Placebo | Pbo | Placebo | Pbo | 2014-07-02 | Overall Survival | OS | 182 | 2014-01-02 | 1 | Alive | Alive During Study | ADSL | LSTALVDT | None |
| 1 | CDISCPILOT01 | 01-701-1015 | 2 | 63 | F | Placebo | Pbo | Placebo | Pbo | 2014-03-06 | Progression Free Survival | PFS | 64 | 2014-01-02 | 1 | Last Tumor Assessment | Last Tumor Assessment | ADRS | ADT | 9 |
| 2 | CDISCPILOT01 | 01-701-1015 | 3 | 63 | F | Placebo | Pbo | Placebo | Pbo | 2014-03-06 | Duration of Response | RSD | 1 | 2014-03-06 | 1 | Last Tumor Assessment | Last Tumor Assessment | ADRS | ADT | 9 |
| 3 | CDISCPILOT01 | 01-701-1023 | 1 | 64 | M | Placebo | Pbo | Placebo | Pbo | 2012-09-02 | Overall Survival | OS | 29 | 2012-08-05 | 1 | Alive | Alive During Study | ADSL | LSTALVDT | None |
| 4 | CDISCPILOT01 | 01-701-1023 | 2 | 64 | M | Placebo | Pbo | Placebo | Pbo | 2012-08-05 | Progression Free Survival | PFS | 1 | 2012-08-05 | 1 | Randomization | Randomization | ADSL | RANDDT | None |
| 5 | CDISCPILOT01 | 01-701-1028 | 1 | 71 | M | Xanomeline High Dose | Xan_Hi | Xanomeline High Dose | Xan_Hi | 2014-01-14 | Overall Survival | OS | 180 | 2013-07-19 | 1 | Alive | Alive During Study | ADSL | LSTALVDT | None |
| 6 | CDISCPILOT01 | 01-701-1028 | 2 | 71 | M | Xanomeline High Dose | Xan_Hi | Xanomeline High Dose | Xan_Hi | 2013-08-30 | Progression Free Survival | PFS | 43 | 2013-07-19 | 0 | Disease Progression | None | ADRS | ADT | 14 |
| 7 | CDISCPILOT01 | 01-701-1033 | 1 | 74 | M | Xanomeline Low Dose | Xan_Lo | Xanomeline Low Dose | Xan_Lo | 2014-04-14 | Overall Survival | OS | 28 | 2014-03-18 | 1 | Alive | Alive During Study | ADSL | LSTALVDT | None |
| 8 | CDISCPILOT01 | 01-701-1033 | 2 | 74 | M | Xanomeline Low Dose | Xan_Lo | Xanomeline Low Dose | Xan_Lo | 2014-03-18 | Progression Free Survival | PFS | 1 | 2014-03-18 | 1 | Randomization | Randomization | ADSL | RANDDT | None |
| 9 | CDISCPILOT01 | 01-701-1034 | 1 | 77 | F | Xanomeline High Dose | Xan_Hi | Xanomeline High Dose | Xan_Hi | 2014-12-30 | Overall Survival | OS | 183 | 2014-07-01 | 1 | Alive | Alive During Study | ADSL | LSTALVDT | None |